MAZZOLA, RICCARDO
MAZZOLA, RICCARDO
Dipartimento di Specialità Medico-Chirurgiche, Scienze Radiologiche e Sanità Pubblica
In reply to Simcock et al
2020-01-01 Magrini, S. M.; Mazzola, R.; Greco, D.; Alongi, F.; Buglione, M.
MR-guidance in clinical reality: Current treatment challenges and future perspectives
2019-01-01 Corradini, S.; Alongi, F.; Andratschke, N.; Belka, C.; Boldrini, L.; Cellini, F.; Debus, J.; Guckenberger, M.; Horner-Rieber, J.; Lagerwaard, F. J.; Mazzola, R.; Palacios, M. A.; Philippens, M. E. P.; Raaijmakers, C. P. J.; Terhaard, C. H. J.; Valentini, V.; Niyazi, M.
Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes
2021-01-01 Alongi, F.; Rigo, M.; Figlia, V.; Cuccia, F.; Giaj-Levra, N.; Nicosia, L.; Ricchetti, F.; Vitale, C.; Sicignano, G.; De Simone, A.; Naccarato, S.; Ruggieri, R.; Mazzola, R.
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis
2019-01-01 Nicosia, L.; Figlia, V.; Mazzola, Riccardo; Napoli, G.; Giaj-Levra, N.; Ricchetti, F.; Rigo, M.; Lunardi, G.; Tomasini, Davide; Bonu, M. L.; Corradini, S.; Ruggieri, R.; Alongi, F.
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal's letter to the editor
2021-01-01 Triggiani, L; Tomasini, D; Mazzola, R
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| In reply to Simcock et al | 1-gen-2020 | Magrini, S. M.; Mazzola, R.; Greco, D.; Alongi, F.; Buglione, M. | |
| MR-guidance in clinical reality: Current treatment challenges and future perspectives | 1-gen-2019 | Corradini, S.; Alongi, F.; Andratschke, N.; Belka, C.; Boldrini, L.; Cellini, F.; Debus, J.; Guckenberger, M.; Horner-Rieber, J.; Lagerwaard, F. J.; Mazzola, R.; Palacios, M. A.; Philippens, M. E. P.; Raaijmakers, C. P. J.; Terhaard, C. H. J.; Valentini, V.; Niyazi, M. | |
| Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes | 1-gen-2021 | Alongi, F.; Rigo, M.; Figlia, V.; Cuccia, F.; Giaj-Levra, N.; Nicosia, L.; Ricchetti, F.; Vitale, C.; Sicignano, G.; De Simone, A.; Naccarato, S.; Ruggieri, R.; Mazzola, R. | |
| Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis | 1-gen-2019 | Nicosia, L.; Figlia, V.; Mazzola, Riccardo; Napoli, G.; Giaj-Levra, N.; Ricchetti, F.; Rigo, M.; Lunardi, G.; Tomasini, Davide; Bonu, M. L.; Corradini, S.; Ruggieri, R.; Alongi, F. | |
| Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal's letter to the editor | 1-gen-2021 | Triggiani, L; Tomasini, D; Mazzola, R |